Insider Cluster (2 insiders) ·Filed Jul 31, 2026

IQV

IQVIA HOLDINGS INC.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $2.3M total
Actionable Insight • Neutral

These small post-earnings sales by the CEO and CFO are routine and not informative. The dominant narrative is IQVIA's strong Q2 beat and raised guidance. Monitor for any larger or more concentrated insider selling in coming weeks, which would be more meaningful.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
IQV ▲ +11.57% at T+20d
NEUTRAL call ✓ call won +11.57% · α vs SPY +10.33% · entry $233.36 → $260.37
Next anchor: T+60d in 24d
Latest observation: T+41 -4.10% FF3 residual α
Entry anchored
Jul 31, 03:59 PM ET
via exchange tick
T+1d
-2.36%
call -2.36% · α -4.12%
$227.85
settled 2mo ago
T+5d
+3.70%
call +3.70% · α +1.67%
$241.99
settled 8w ago
T+20d
+11.57%
call +11.57% · α +10.33%
$260.37
settled 5w ago
T+60d
—
call — · α —
—
in 24d

Price Chart

Loading chart...

Executive Summary

CEO Ari Bousbib and CFO Eric Sherbet sold a combined $2.35M in open-market transactions on July 29, 2026, following IQVIA's strong Q2 earnings beat and raised guidance. The total value is negligible (≈0.006% of market cap), likely reflecting routine post-earnings portfolio rebalancing or tax-related sales rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$2.4M
Insiders
2

Key Facts

  • Two insider open-market sales: CEO Ari Bousbib sold 4,500 shares at $247.10 ($1.10M) and CFO Eric Sherbet sold 5,000 shares at $249.16 ($1.25M).
  • Total cluster value of $2.35M is only ~0.006% of IQVIA's $39.1B market cap.
  • Sales occurred 1 day after IQVIA reported Q2 2026 results with revenue of $4.368B (+8.7% YoY) and adjusted EPS of $3.15 (+12.1%), both above consensus, and raised full-year guidance.
  • Cross-filing context shows Bousbib also exercised derivatives and disposed shares to issuer on the same day, consistent with option exercise and tax withholding.

Financial Impact

Insider sales of $2.35M are trivial relative to $39.1B market cap; no material financial impact.

insider ownership

Risk Factors

  • If additional executives begin selling meaningful amounts, it could signal peak valuation concerns.
  • Insider sales timed after positive results may be misread as profit-taking, creating short-term noise.

Market Snapshot

Exchange
NYSE
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
76% bullish (29 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IQV-1785564265801
9 reports for IQV
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IQV — sortable, filterable
TypeNow
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 4/10
$236.05 $263.84▲ +11.77%▲ +12.37%$257.50 (+9.09%)
Jul 31, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$233.36 $260.37▲ +11.57%▲ +10.33%$257.50 (+10.34%)
Jul 28, 2026
9w ago
8-K
BULLISH ★ 7/10
$242.94 $259.42▲ +6.78%▲ +3.40%$257.50 (+5.99%)
Jun 11, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$181.46 $207.85▲ +14.54%▲ +12.76%$257.50 (+41.90%)
Jun 4, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$183.45 $205.97▲ +12.28%▲ +10.41%$257.50 (+40.37%)
Jun 3, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$186.85 $207.04▲ +10.81%▲ +12.43%$257.50 (+37.81%)
Mar 30, 2026
26w ago
Court Ruling
NEUTRAL ★ 1/10
$166.16 $158.98▼ −4.32%▼ −16.94%$257.50 (+54.97%)
Mar 17, 2026
28w ago
Court Ruling
BULLISH ★ 6/10
$168.43 $178.10▲ +5.74%▲ +1.40%$257.50 (+52.88%)
Feb 27, 2026
30w ago
DEFA14A
NEUTRAL ★ 3/10
$174.24 $166.02▼ −4.72%▲ +3.22%$257.50 (+47.79%)
Showing 9 of 9

US Market Status

Market Open — Closes in 3h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 1, 2026